Clinical Trial Update: Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating Tripterygium Capsule for early ankylosing spondylitis in Phase 2 and Phase 3, sponsored by Sun Yat-sen University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Tripterygium Capsule (Tripterygium wilfordii)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Early Ankylosing Spondylitis | Phase 2, Phase 3 | Status: UNKNOWN